A state investigation recently found a list of violations at Laurel Ridge Treatment Center, which it said put patients in ...

This novel therapy offers the first FDA-approved option to address the root cause of this ultra-rare condition, which causes progressive muscle weakness impairing walking, breathing, and swallowing.

The First And Only Treatment For Adults And Children Living With Thymidine Kinase 2 Deficiency (Tk2d). <li /> Approved indication: KYGEVVITM (doxecitine and doxribtimine) powder for oral solution (2 ...

By Brittany Hailer for The Marshall Project. Broadcast version by Farah Siddiqi for Ohio News Connection reporting for the ...

The Kirkland-based nonprofit has opened a short-term, voluntary housing program to support young adults ages 18 to 24 who are ...

This year’s program will also feature guest speaker Peter Mutabazi, a Ugandan-born foster father, entrepreneur, and advocate whose journey from street child to global voice for children in foster care ...

WHEELING — The Easterseals Rehabilitation Center board of directors named The Intelligencer and Wheeling News-Register ...

Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of ...

“The approval today of KYGEVVI® (doxecitine and doxribtimine), provides real hope for patients and families living with this devastating disease,” said Angela Lek, PhD, interim Chief Research Officer ...

In the United States, 1 in every 250 people has inherited a genetic variant that leads to dangerously high cholesterol levels ...

Inspired in part by a romantic comedy of the same name, this phenomenon has informally come to be known as “failure to launch ...

The U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor, for the treatment of adults and children one ...